NCT03209674 Registry for the Improvement of Postoperative OutcomeS in Cardiac and Thoracic surgEry
| NCT ID | NCT03209674 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CMC Ambroise Paré |
| Condition | Heart Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,000 participants |
| Start Date | 2012-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,000 participants in total. It began in 2012-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The registry for the improvement of postoperative outcomes in cardiac and thoracic surgery aims to prospectively collect data in order to test the association between various preoperative and per-operative variables ; and several postoperative outcomes such as mortality, shock, redo surgery, sepsis and extracorporeal life-support.
Eligibility Criteria
Inclusion Criteria: * all patients eligible for cardiac or thoracic surgery Exclusion Criteria: * non applicable
Contact & Investigator
Alain Brusset, MD
✉ brusseta@club-internet.frMarie-Caroline Merand
STUDY CHAIR
CMC Ambroise Paré
Frequently Asked Questions
Who can join the NCT03209674 clinical trial?
This trial is open to participants of all sexes, studying Heart Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03209674 currently recruiting?
Yes, NCT03209674 is actively recruiting participants. Contact the research team at brusseta@club-internet.fr for enrollment information.
Where is the NCT03209674 trial being conducted?
This trial is being conducted at Neuilly-sur-Seine, France.
Who is sponsoring the NCT03209674 clinical trial?
NCT03209674 is sponsored by CMC Ambroise Paré. The principal investigator is Marie-Caroline Merand at CMC Ambroise Paré. The trial plans to enroll 8,000 participants.